No sector is immune from the threat of cybersecurity attacks. How can this risk be assessed from a credit and governance perspective in securitisation markets?
Insights
Risk assets rebounded in Q2 as worries about tariffs eased and earnings growth proved resilient. Can the trend continue to hold on?
How pharmaceutical tariffs and drug pricing reform could help secure biopharma innovation over the long run.
In a world of constant change, the key to investment success lies in combining duration and innovation.
What do current market dynamics mean for asset allocation? The Market GPS Multi-Asset Quarterly highlights key drivers and positioning.
In this episode, we explore how Janus Henderson is navigating geopolitical uncertainty and fostering partnerships for a brighter future.
Are shifting market dynamics building the need for real diversification in investors’ portfolios?
As AI makes inroads into healthcare, opportunities for patients and investors grow.
Janus Henderson’s ‘Partnerships for a Brighter Future’ event in New York discussed AI and bionic enhancements that can support human resilience.
Dinesh Kuhadas, Credit Analyst on the Australian Fixed Interest Team, discusses the renewed appeal of corporate subordinated debt for both issuers and investors, highlighting its benefits and emphasising the importance of active management to capitalise on opportunities within this evolving market segment.
How AI and accelerating technology adoption is disrupting sports.